glp-1 obesity drug news today oct 23 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ New oral GLP-1 drug delivers
Description
Lawsuits over severe side effects from taking GLP-1 medications Ozempic, Wegovy, Mounjaro, Trulicity, and Rybelsus
Learn benefits, risks, and how Isya Aesthetics creates personalized treatment plans
The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
Obesity and type 2 diabetes remain critical global health challenges, with rising prevalence demanding innovative treatment approaches
